Boston Scientific's SpyGlass(R) Direct Visualization System to Be Prominently Featured at Digestive Disea...(em at the one-yearanniversary of its wor...)

Date:5/16/2008

em at the one-year anniversary of its worldwide launch," said Michael P. Phalen, President, Boston Scientific Endoscopy. "We have received positive feedback from the GI community regarding the ability of the SpyGlass System to provide excellent direct visual access to the bile ducts. We have nearly 300 patients enrolled in our comprehensive patient registry, which enables us to build further evidence of the clinical utility of cholangioscopy using the SpyGlass System." Schedule of SpyGlass Patient Registry Presentations:

Tuesday, May 20th (all times are PT)

-- Peroral Cholangioscopy Using a Disposable Steerable Single Operator

Catheter for Biliary Stone Therapy and Assessment of Indeterminate

Strictures - A Multi-Center Experience

Yang K. Chen, M.D., Division of Gastroenterology and Hepatology,

University of Colorado at Denver and Health Sciences Center, and

primary principal investigator of the SpyGlass registry, will present

results that document the performance and utility of PO using the

SpyGlass System over a 12-month period. The presentation will take

place at 4:00 p.m. in Room 1 at the San Diego Convention Center.

-- Peroral Cholangioscopy Guided Stone Therapy - Report of an

International Multi-Center Registry

Mansour Parsi, M.D., Department of Gastroenterology and Hepatology, The

Cleveland Clinic Foundation, and principal investigator in the SpyGlass

registry, will present results on a subset of patients that underwent

PO using the SpyGlass System to determine its effectiveness in the

treatment of difficult-to-remove biliary stones and assess its utility

for the detection of missed stones by ERC. The presentation will take

place at 4:36 p.m. in Room 1 at the San Diego Convention Center.

-- Biopsy of Indeterminate Biliary Strictures - Does Direct Visualization

Help?

'/>"/>

SOURCE Boston Scientific Corporation Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5
Related biology technology :

1. Boston Scientific Announces Program to Analyze Latitude(R) Patient Monitoring Data
2. Boston Scientific Announces European Approval and Market Launch of New Family of Advanced Pacemakers
3. WIPO Panel Rules Boston Scientific Liberte(R) and TAXUS(R) Liberte(R) Stents Do Not Infringe Medinol Patents
4. Fraunhofer and Boston University Hosted Prestigious SME Tour
5. Boston-Based BioDefense Corp. Announces New UK Partnership to Expand Markets for Biohazard Protection
6. Boston Scientific Announces Results for First Quarter Ended March 31, 2008
7. Angiotechs Corporate Partner, Boston Scientific, Reports Canadian Approval for TAXUS(R) Liberte(R) Stent System
8. Boston Scientific Receives Canadian Approval for TAXUS(R) Liberte(R) Stent System
9. Boston Scientific and CryoCor Announce Signing of Definitive Merger Agreement
10. Boston Scientific and Surgi-Vision Announce Licensing Agreement for MRI-Safe Technology
11. Boston Scientific Announces Japanese Approval of Heart Failure Lead